United States Automated Cell Culture Market Research Report to 2032

US Automated Cell Culture Market Highlighted Trends & Dynamics

In 2019, the United States dominated the automated cell culture market, holding a substantial market share of 85.74%, valued at USD 404.8 million. The market is anticipated to maintain a robust growth trajectory with a projected Compound Annual Growth Rate (CAGR) of 13.08% during the forecast period. Meanwhile, Canada's market, valued at USD 67.3 million in 2019, is expected to witness a higher CAGR of 13.77%.
The modular automation segment played a pivotal role, capturing the majority of the market at 66.46% in 2019, with a market value of USD 313.8 million. This segment is poised for continued growth, expected to register a higher CAGR of 13.35% during the forecast period. In comparison, the whole lab automation segment, valued at USD 158.4 million in 2019, is projected to exhibit a CAGR of 12.83%.

Among equipment types, the automated liquid handling systems segment emerged as the market leader in 2019, commanding a share of 32.10% and a market value of USD 151.5 million. This segment is forecasted to sustain growth with an expected CAGR of 13.04%. The microplate readers segment, valued at USD 125.2 million in 2019, is projected to exhibit a CAGR of 13.34%. Notably, the automated storage & retrieval systems (ASRS) segment is anticipated to register the highest CAGR of 13.83%.

In terms of applications, the biopharmaceutical production segment claimed the largest market share at 22.04% in 2019, amounting to USD 104.1 million. This segment is projected to maintain a steady CAGR of 13.34% during the forecast period. The tissue engineering & regenerative medicine segment, valued at USD 81.9 million in 2019, is expected to exhibit a CAGR of 13.06%. On the other hand, the drug screening and development segment is anticipated to witness the highest CAGR of 13.83%.

In the end-user segment, pharmaceutical & biotechnology companies held the lion's share at 37.67% in 2019, with a market value of USD 177.8 million. This segment is poised for substantial growth, projected to register the highest CAGR of 13.93% during the forecast period. The research institutes segment, valued at USD 154.2 million in 2019, is expected to exhibit a CAGR of 12.84%.

Once again, within the modular automation segment, the market leader held a share of 66.31% in 2019, with a value of USD 268.5 million. This segment is expected to continue its dominance, registering a higher CAGR of 13.25% during the forecast period. Meanwhile, the whole lab automation segment, valued at USD 136.4 million in 2019, is projected to exhibit a CAGR of 12.73%.

Conclusively, the automated cell culture market's dynamic growth is evident across various segments, reflecting the industry's robust prospects and technological advancements.

Report Attribute/Metric	Details
Market Size 2022	USD 4.6 billion
Market Size 2023	USD 4.9 billion
Market Size 2030	USD 8.62 billion
Compound Annual Growth Rate (CAGR)	8.18% (2023-2030)
Base Year	2022
Market Forecast Period	2023-2030
Historical Data	2018 & 2021
Market Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Product, Application, End-user, and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Hitachi Ltd (Japan), Beckman Coulter Inc. (US), Thermo Fisher Scientific (US), Hamilton Company (US), Sartorius Stedim Biotech Group (Germany)
Key Market Opportunities	Development and Maintenance of Expertise.
Key Market Dynamics	New Product Launches and Technology Developments How much is the Automated Cell Culture market?